Learn More
Apexbio Technology LLC Tonabersat 175013-84-0 50mg

Supplier: Apexbio Technology LLC A388350
Tonabersat (CAS 175013-84-0) is a gap-junction modulator targeting neuronal and satellite glial cell communication within the trigeminal ganglion It is designed to modulate gap-junction pathways thereby regulating neurological signaling associated with migraine aura and epilepsy Tonabersat exerts its biological activity primarily through inhibition of gap-junction communication leading to decreased cortical spreading depression (CSD) a process implicated in migraine pathophysiology Based on these pharmacological properties Tonabersat holds research potential in the study of migraine and epilepsy
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.